News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

The Quality Enterprise—What Is It, Where Is It Going, and How Will It Be Impacted by Healthcare Reform?

The Quality Enterprise: Q & A With the 'Nation's' Chief Pharmacist, Rear Admiral Scott F. Giberson

By

July 28th 2013

Module 5: What's Next?

ByL. Allen Dobson, Jr, MD,Marcia Guida James, MS, MBA,Margaret E. Oâ€™Kane, MPH,Peter Salgo, MD,Jed Weissberg, MD

July 28th 2013

Module 4: The Quality Enterprise and VBP Principles-Case Studies

ByJohn T. Berthiaume, MD,L. Allen Dobson, Jr, MD,George K. Heuser, MD,Peter Salgo, MD,Jed Weissberg, MD

July 28th 2013

Module 3: Measuring Quality in the Quality Enterprise

ByL. Allen Dobson, Jr, MD,Marcia Guida James, MS, MBA,Margaret E. Oâ€™Kane, MPH,Peter Salgo, MD,Jed Weissberg, MD

July 28th 2013

Module 2: Policy and Value-Based Purchasing

ByMarcia Guida James, MS, MBA,Margaret E. Oâ€™Kane, MPH,Peter Salgo, MD,Jed Weissberg, MD

July 28th 2013

Module 1: The Environment

ByMarcia Guida James, MS, MBA,Margaret E. Oâ€™Kane, MPH,Peter Salgo, MD,Jed Weissberg, MD

July 27th 2013

Participating Faculty: The Quality Enterprise-What Is It, Where Is It Going, and How Will It Be Impacted by Healthcare Reform? An Expert Roundtable

By

July 27th 2013

Trending on AJMC

DOJ Abandons Olmstead Defense as Texas v Kennedy Advances

FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes

Myasthenia Gravis Linked to Greater Longevity Than Multiple Sclerosis

FDA Approves Rusfertide to Treat Erythrocytosis In Polycythemia Vera

Unvaccinated COVID-19 Infection Tied to Higher Myocarditis Risk